Geron
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Geron and other ETFs, options, and stocks.About GERN
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies.
GERN Key Statistics
Stock Snapshot
As of today, Geron(GERN) shares are valued at $1.38. The company's market cap stands at 942.77M, with a P/E ratio of -11.56.
As of 2025-12-12, Geron(GERN) stock has fluctuated between $1.31 and $1.39. The current price stands at $1.38, placing the stock +5.3% above today's low and -0.8% off the high.
Geron(GERN) shares are trading with a volume of 10.47M, against a daily average of 6.72M.
In the last year, Geron(GERN) shares hit a 52-week high of $4.01 and a 52-week low of $1.04.
In the last year, Geron(GERN) shares hit a 52-week high of $4.01 and a 52-week low of $1.04.
GERN News
H.C. Wainwright analyst Emily Bodnar has reiterated their neutral stance on GERN stock, giving a Hold rating on November 28. TipRanks Cyber Monday Sale Claim 60...
Geron (GERN) Corporation announced a strategic restructuring plan intended to position the Company for long-term value creation for patients and shareholders an...